Feasibility of low dose chest CT for virtual bronchoscopy navigation in a porcine model

Insu Kim, Geewon Lee, Jung Seop Eom, Hyo Yeong Ahn, Ahreum Kim, Insu Kim, Geewon Lee, Jung Seop Eom, Hyo Yeong Ahn, Ahreum Kim

Abstract

Background: Virtual bronchoscopy navigation (VBN) is widely used for assistance in the histological examination of lung nodules. However, little is known about the optimal CT radiation dose for VBN. Therefore, we performed an animal study to evaluate the feasibility of low dose CT (LDCT) for VBN.

Methods: Ten pigs underwent standard dose CT (as a reference) and four different LDCT protocols: LDCT 1, 120 kVp, 15 mAs; LDCT 2, 120 kVp, 8 mAs; LDCT 3, 100 kVp, 7 mAs; and LDCT 4, 100 kVp, 4 mAs. As targets for the VBN, 10 mm virtual lesions were created in the central and peripheral bronchi. To assess the performance of the VBN, the navigation direction (direction of reconstructed pathways to the target) and the number of branching's (the number of peripheral bronchi to the target) were evaluated.

Results: The mean effective doses significantly differed across the four LDCTs (P < 0.001). For both central and peripheral virtual targets, there were significant differences in the accuracy of the navigation direction and the number of branching's of the VBNs across the four LDCTs (P < 0.001 for all). Regarding the accuracy of the navigation direction and the number of branching's, the areas under the curves of the ROCs were 0.9352 and 0.9324, respectively, for central virtual targets, and 0.8696 and 0.8783, respectively, for peripheral virtual targets. Youden's index indicated that the optimal effective CT scan dose for both central and peripheral virtual targets was 0.238 mSv.

Conclusions: LDCT is feasible for VBN.

Keywords: Bronchoscopy; Diagnosis; Lung neoplasms; Multisection computed tomography; Radiation.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Representative images of standard and low dose CT scans. a Standard dose CT. b-e Low dose CT scans 1–4
Fig. 2
Fig. 2
Virtual targets for the virtual bronchoscopy navigation. a Creation of a three-dimensional virtual target (arrow) located on the peripheral bronchus (arrowhead) using LungPoint software. b Central (red circle) and peripheral (blue circle) virtual targets created in the middle and outer one-third of the lung parenchyma, respectively
Fig. 3
Fig. 3
Guidance screen of the VBN. The red line represents all bronchial pathways and the blue line is the automatically searched-for route with the closest access to the virtual target. The navigation direction accuracy was defined as the concordance in the progression of the blue line between the VBN using low dose CT and that using standard dose CT. The number of branching’s was defined as the number of red lines that directly branched from the blue line, and the accuracy of the number of branching’s was defined according to the concordance of this number between the VBNs using low dose and standard dose CT. VBN = virtual bronchoscopy navigation
Fig. 4
Fig. 4
ROC curves of the optimal effective low dose CT scan doses for VBN performance. a ROC curve of the navigation direction for central virtual targets. b ROC curve of the number of branching’s for central virtual targets. c ROC curve of the navigation direction for peripheral virtual targets. d ROC curve of the number of branching’s for peripheral virtual targets. VBN = virtual bronchoscopy navigation

References

    1. National Lung Screening Trial Research Team. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409. doi: 10.1056/NEJMoa1102873.
    1. Hasan N, Kumar R, Kavuru MS. Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers. Lung. 2014;192:639–648. doi: 10.1007/s00408-014-9636-z.
    1. Nanavaty P, Alvarez MS, Alberts WM. Lung cancer screening: advantages, controversies, and applications. Cancer Control. 2014;21:9–14. doi: 10.1177/107327481402100102.
    1. National Comprehensive Cancer Network. NCCN Clinical Practical Guidelines in Oncology (NCCN Guidelines) - Lung Cancer Screening. Version 2. 2019. . Accessed 12 Jan 2019.
    1. Kurimoto N, Miyazawa T, Okimasa S, Maeda A, Oiwa H, Miyazu Y, Murayama M. Endobronchial ultrasonography using a guide sheath increases the ability to diagnose peripheral pulmonary lesions endoscopically. Chest. 2004;126:959–965. doi: 10.1378/chest.126.3.959.
    1. Eberhardt R, Anantham D, Ernst A, Feller-Kopman D, Herth F. Multimodality bronchoscopic diagnosis of peripheral lung lesions: a randomized controlled trial. Am J Respir Crit Care Med. 2007;176:36–41. doi: 10.1164/rccm.200612-1866OC.
    1. Gould MK, Donington J, Lynch WR, Mazzone PJ, Midthun DE, Naidich DP, Wiener RS. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:e93S–120S. doi: 10.1378/chest.12-2351.
    1. Asano F, Matsuno Y, Tsuzuku A, Anzai M, Shinagawa N, Yamazaki K, Ishida T, Moriya H. Diagnosis of peripheral pulmonary lesions using a bronchoscope insertion guidance system combined with endobronchial ultrasonography with a guide sheath. Lung Cancer. 2008;60:366–373. doi: 10.1016/j.lungcan.2007.10.022.
    1. Asano F, Eberhardt R, Herth FJ. Virtual bronchoscopic navigation for peripheral pulmonary lesions. Respiration. 2014;88:430–440. doi: 10.1159/000367900.
    1. Ishida T, Asano F, Yamazaki K, Shinagawa N, Oizumi S, Moriya H, Munakata M, Nishimura M, Virtual Navigation in Japan Trial Group Virtual bronchoscopic navigation combined with endobronchial ultrasound to diagnose small peripheral pulmonary lesions: a randomised trial. Thorax. 2011;66:1072–1077. doi: 10.1136/thx.2010.145490.
    1. Hayama M, Izumo T, Matsumoto Y, Chavez C, Tsuchida T, Sasada S. Complications with endobronchial ultrasound with a guide sheath for the diagnosis of peripheral pulmonary lesions. Respiration. 2015;90:129–135. doi: 10.1159/000431383.
    1. McCollough CH, Schueler BA. Calculation of effective dose. Med Phys. 2000;27:828–837. doi: 10.1118/1.598948.
    1. Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and its corresponding Youden index to discriminate individuals using pooled blood samples. Epidemiology. 2005;16:73–81. doi: 10.1097/.
    1. Eberhardt R, Kahn N, Gompelmann D, Schumann M, Heussel CP, Herth FJ. LungPoint--a new approach to peripheral lesions. J Thorac Oncol. 2010;5:1559–1563. doi: 10.1097/JTO.0b013e3181e8b308.
    1. Tamiya M, Okamoto N, Sasada S, Shiroyama T, Morishita N, Suzuki H, Yoshida E, Hirashima T, Kawahara K, Kawase I. Diagnostic yield of combined bronchoscopy and endobronchial ultrasonography, under LungPoint guidance for small peripheral pulmonary lesions. Respirology. 2013;18:834–839. doi: 10.1111/resp.12095.
    1. Wang Memoli JS, Nietert PJ, Silvestri GA. Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. Chest. 2012;142:385–393. doi: 10.1378/chest.11-1764.
    1. Omori H, Nakashima R, Otsuka N, Mishima Y, Tomiguchi S, Narimatsu A, Nonami Y, Mihara S, Koyama W, Marubayashi T, Morimoto Y. Emphysema detected by lung cancer screening with low-dose spiral CT: prevalence, and correlation with smoking habits and pulmonary function in Japanese male subjects. Respirology. 2006;11:205–210. doi: 10.1111/j.1440-1843.2006.00827.x.
    1. Wilson DO, Weissfeld JL, Balkan A, Schragin JG, Fuhrman CR, Fisher SN, Wilson J, Leader JK, Siegfried JM, Shapiro SD, Sciurba FC. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med. 2008;178:738–744. doi: 10.1164/rccm.200803-435OC.
    1. Ali MS, Trick W, Mba BI, Schragin JG, Fuhrman CR, Fisher SN, Wilson J, Leader JK, Siegfried JM, Shapiro SD, Sciurba FC. Radial endobronchial ultrasound for the diagnosis of peripheral pulmonary lesions: a systematic review and meta-analysis. Respirology. 2017;22:443–453. doi: 10.1111/resp.12980.
    1. Asano F, Ishida T, Shinagawa N, Sukoh N, Anzai M, Kanazawa K, Tsuzuku A, Morita S. Virtual bronchoscopic navigation without X-ray fluoroscopy to diagnose peripheral pulmonary lesions: a randomized trial. BMC Pulm Med. 2017;17:184. doi: 10.1186/s12890-017-0531-2.
    1. Smith-Bindman R, Lipson J, Marcus R, Kim KP, Mahesh M, Gould R, Berrington de González A, Miglioretti DL. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med. 2009;169:2078–2086. doi: 10.1001/archinternmed.2009.427.
    1. Sodickson A, Baeyens PF, Andriole KP, Prevedello LM, Nawfel RD, Hanson R, Khorasani R. Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology. 2009;251:175–184. doi: 10.1148/radiol.2511081296.
    1. 1990 Recommendations of the International Commission on Radiological Protection. Ann ICRP 1991;21:1–201.
    1. Judge EP, Hughes JM, Egan JJ, Maguire M, Molloy EL, O'Dea S. Anatomy and bronchoscopy of the porcine lung. A model for translational respiratory medicine. Am J Respir Cell Mol Biol. 2014;51:334–343. doi: 10.1165/rcmb.2013-0453TR.
    1. Kannan R, Przekwas A. A computational model to detect and quantify a primary blast lunginjury using near-infrared optical tomography. Int J Numer Meth Biomed Engng. 2011;27:13–28. doi: 10.1002/cnm.1406.
    1. Kannan R, Przekwas A. A near-infrared spectroscopy computational model for cerebral hemodynamics. Int J Numer Meth Biomed Engng. 2012;28:1093–1106. doi: 10.1002/cnm.2480.

Source: PubMed

3
Suscribir